Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-09

Clinical Trial Update: A Real-world Study of Long-acting Growth Hormone Injection for Turner Syndrome

View source ↗

Summary

A real-world study evaluating a long-acting growth hormone injection for Turner syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Long-acting growth hormone injection (somatropin)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Turner Syndrome | Status: COMPLETED